Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM 2023
Biotech
JPM's private capital team ‘actively looking’ at psychedelics
With the stage set for the first psychedelic-based therapy to nab FDA approval, even J.P. Morgan can't resist the allure.
Max Bayer
Feb 28, 2024 7:00am
Have mRNA cancer vaccines arrived? Biopharma execs weigh in
Jan 25, 2023 10:30am
How 2 biotechs survived 2022’s stormy seas, per their CEOs
Jan 18, 2023 10:00am
Big data, labor shortages and slow M&A top medtech CEOs' minds
Jan 18, 2023 9:50am
Tessera makes the case for gene writing tech at JPM
Jan 17, 2023 12:56pm
Illumina faces EU's maximum fine for closing Grail deal: report
Jan 13, 2023 11:00am
